April 7, 2022 AbbVie faces a class action that alleges the pharma co. misled investors by “condition[ing]” them to believe Rinvoq was far safer than Xeljanz.
![AbbVie, Zeltiq Aesthetics’ CoolSculpting System Can Cause Permanent Body Deformities, Class Action Alleges [DISMISSED]](/media/coolsculpting-newswire-thumb.jpg)
June 2, 2021 A class action alleges AbbVie’s purportedly fat-reducing CoolSculpting System can cause permanent deformities to a person’s body by damaging tissue in the targeted area.
September 16, 2020 A class action alleges AbbVie, Allergan and Forest Labs conspired to suppress market competition for Bystolic, a blockbuster high blood pressure treatment drug.
September 25, 2019 Allergan PLC is on the receiving end of a proposed class action lawsuit centered on a potential merger with AbbVie, Inc., the details of which the case alleges were not fully disclosed to stockholders.
April 1, 2019 A lawsuit focuses on three pharmaceutical companies’ alleged conspiracy to maintain a monopoly over the market for arthritis treatment Humira.
